BCG vaccination of guinea pigs modulates Mycobacterium tuberculosis-induced CCL5 (RANTES) production in vitro and in vivo

Tuberculosis

Volumn 86, Issue 6, 2006, Pages 419-429

  Skwor, Troy A ^a   Sedberry Allen, Shannon ^a   Mackie, John T ^b   Russell, Karen ^b   Berghman, Luc R ^c   McMurray, David N ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

CCL5; IFN ; Macrophage; MHC II; Mycobacterium; Pleurisy

Indexed keywords

BCG VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BCG VACCINATION; CELL POPULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUINEA PIG; HISTOPATHOLOGY; LEUKOCYTE; LYMPHOCYTE; MACROPHAGE; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLEURA EFFUSION; PLEURISY; PRIORITY JOURNAL; RNA ANALYSIS; TUBERCULOSIS;

ANIMALS; BCG VACCINE; CELLS, CULTURED; CHEMOKINE CCL5; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GUINEA PIGS; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MALE; PROTEIN BIOSYNTHESIS; RANTES; RNA, MESSENGER; SPLEEN; TUBERCULOSIS, PLEURAL; VACCINATION;

EID: 33750052884     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2005.12.002     Document Type: Article

References (49)

1. Dye C., Scheele S., Dolin P., Pathania V., and Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282 (1999) 677-686
2. Seibert A.F., Haynes Jr. J., Middleton R., and Bass Jr. J.B. Tuberculous pleural effusion. Twenty-year experience. Chest 99 (1991) 883-886
3. Aktogu S., Yorgancioglu A., Cirak K., Kose T., and Dereli S.M. Clinical spectrum of pulmonary and pleural tuberculosis: a report of 5480 cases. Eur Respir J 9 (1996) 2031-2035
4. Frye M.D., Pozsik C.J., and Sahn S.A. Tuberculous pleurisy is more common in AIDS than in non-AIDS patients with tuberculosis. Chest 112 (1997) 393-397
5. Hill A.R., Premkumar S., Brustein S., Vaidya K., Powell S., Li P.W., et al. Disseminated tuberculosis in the acquired immunodeficiency syndrome era. Am Rev Respir Dis 144 (1991) 1164-1170
6. Roche P.W., Triccas J.A., and Winter N. BCG vaccination against tuberculosis: past disappointments and future hopes. Trends Microbiol 3 (1995) 397-401
7. Tuberculosis Research Centre (ICMR) C. Fifteen year follow up of trial of BCG vaccines in south India for tuberculosis prevention. Indian J Med Res 110 (1999) 56-69
8. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271 (1994) 698-702
9. Mederle I., Le Grand R., Vaslin B., Badell E., Vingert B., Dormont D., et al. Mucosal administration of three recombinant Mycobacterium bovis BCG-SIVmac251 strains to cynomolgus macaques induces rectal IgAs and boosts systemic cellular immune responses that are primed by intradermal vaccination. Vaccine 21 (2003) 4153-4166
10. McMurray D.N., Collins F.M., Dannenberg Jr. A.M., and Smith D.W. Pathogenesis of experimental tuberculosis in animal models. In: Shinnick T.M. (Ed). Current topic in microbiology and immunology vol. 215 (1996), Springer, Berlin, Heidelberg
11. Botha T., and Ryffel B. Reactivation of latent tuberculosis infection in TNF-deficient mice. J Immunol 171 (2003) 3110-3118
12. Roach D.R., Bean A.G., Demangel C., France M.P., Briscoe H., and Britton W.J. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168 (2002) 4620-4627
13. Holscher C., Atkinson R.A., Arendse B., Brown N., Myburgh E., Alber G., et al. A protective and agonistic function of IL-12p40 in mycobacterial infection. J Immunol 167 (2001) 6957-6966
14. Sugawara I., Yamada H., Kazumi Y., Doi N., Otomo K., Aoki T., et al. Induction of granulomas in interferon-gamma gene-disrupted mice by avirulent but not by virulent strains of Mycobacterium tuberculosis. J Med Microbiol 47 (1998) 871-877
15. Chensue S.W., Warmington K., Ruth J.H., Lukacs N., and Kunkel S.L. Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks. J Immunol 159 (1997) 3565-3573
16. Fine J.S., Rojas-Triana A., Jackson J.V., Engstrom L.W., Deno G.S., Lundell D.J., et al. Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10. Inflammation 27 (2003) 161-174
17. Barnes P.F., Fong S.J., Brennan P.J., Twomey P.E., Mazumder A., and Modlin R.L. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol 145 (1990) 149-154
18. Okamoto M., Kawabe T., Iwasaki Y., Hara T., Hashimoto N., Imaizumi K., et al. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions. J Lab Clin Med 145 (2005) 88-93
19. Chensue S.W., Warmington K.S., Allenspach E.J., Lu B., Gerard C., Kunkel S.L., et al. Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. J Immunol 163 (1999) 165-173
20. Park J.S., Kim Y.S., Jee Y.K., Myong N.H., and Lee K.Y. Interleukin-8 production in tuberculous pleurisy: role of mesothelial cells stimulated by cytokine network involving tumour necrosis factor-alpha and interleukin-1 beta. Scand J Immunol 57 (2003) 463-469
21. Bacon K.B., Premack B.A., Gardner P., and Schall T.J. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269 (1995) 1727-1730
22. Schall T.J., Bacon K., Toy K.J., and Goeddel D.V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347 (1990) 669-671
23. Dorner B.G., Scheffold A., Rolph M.S., Huser M.B., Kaufmann S.H., Radbruch A., et al. MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Proc Natl Acad Sci USA 99 (2002) 6181-6186
24. Zou W., Borvak J., Marches F., Wei S., Galanaud P., Emilie D., et al. Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12. J Immunol 165 (2000) 4388-4396
25. Taub D.D., Turcovski-Corrales S.M., Key M.L., Longo D.L., and Murphy W.J. Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. J Immunol 156 (1996) 2095-2103
26. Devergne O., Marfaing-Koka A., Schall T.J., Leger-Ravet M.B., Sadick M., Peuchmaur M., et al. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 179 (1994) 1689-1694
27. Saukkonen J.J., Bazydlo B., Thomas M., Strieter R.M., Keane J., and Kornfeld H. Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth. Infect Immun 70 (2002) 1684-1693
28. Sadek M.I., Sada E., Toossi Z., Schwander S.K., and Rich E.A. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Respir Cell Mol Biol 19 (1998) 513-521
29. Wang Y., Kelly C.G., Karttunen J.T., Whittall T., Lehner P.J., Duncan L., et al. CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity 15 (2001) 971-983
30. Kurashima K., Mukaida N., Fujimura M., Yasui M., Nakazumi Y., Matsuda T., et al. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am J Respir Crit Care Med 155 (1997) 1474-1477
31. Orme I.M., McMurray D.N., and Belisle J.T. Tuberculosis vaccine development: recent progress. Trends Microbiol 9 (2001) 115-118
32. Lasco T.M., Yamamoto T., Yoshimura T., Allen S.S., Cassone L., and McMurray D.N. Effect of Mycobacterium bovis BCG vaccination on Mycobacterium-specific cellular proliferation and tumor necrosis factor alpha production from distinct guinea pig leukocyte populations. Infect Immun 71 (2003) 7035-7042
33. Lyons M.J., Yoshimura T., and McMurray D.N. Mycobacterium bovis BCG vaccination augments interleukin-8 mRNA expression and protein production in guinea pig alveolar macrophages infected with Mycobacterium tuberculosis. Infect Immun 70 (2002) 5471-5478
34. Jeevan A., Yoshimura T., Foster G., and McMurray D.N. Effect of Mycobacterium bovis BCG vaccination on interleukin-1 beta and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria. Infect Immun 70 (2002) 1245-1253
35. Skwor T.A., Cho H., Cassidy C., Yoshimura T., and McMurray D.N. Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages. J Leukoc Biol (2004)
36. Phalen S.W., and McMurray D.N. T-lymphocyte response in a guinea pig model of tuberculous pleuritis. Infect Immun 61 (1993) 142-145
37. Allen S.S., and McMurray D.N. Coordinate cytokine gene expression in vivo following induction of tuberculous pleurisy in guinea pigs. Infect Immun 71 (2003) 4271-4277
38. Cho H., Lasco T.M., Allen S.S., Yoshimura T., and McMurray D.N. Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages. Infect Immun 73 (2005) 1367-1376
39. In: Badewa A.P., Quinton L.J., Shellito J.E., and Mason C.M. (Eds). Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis. Tuberculosis (Edinburgh) 85 (2005) 185-195
40. Klunner T., Bartels T., Vordermeier M., Burger R., and Schafer H. Immune reactions of CD4- and CD8-positive T cell subpopulations in spleen and lymph nodes of guinea pigs after vaccination with Bacillus Calmette Guerin. Vaccine 19 (2001) 1968-1977
41. Walzer T., Marcais A., Saltel F., Bella C., Jurdic P., and Marvel J. Cutting edge: immediate RANTES secretion by resting memory CD8T cells following antigenic stimulation. J Immunol 170 (2003) 1615-1619
42. Swanson B.J., Murakami M., Mitchell T.C., Kappler J., and Marrack P. RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR-dependent process. Immunity 17 (2002) 605-615
43. Catalfamo M., Karpova T., McNally J., Costes S.V., Lockett S.J., Bos E., et al. Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity 20 (2004) 219-230
44. Roper W.H., and Waring J.J. Primary serofibrinous pleural effusion in military personnel. Am Rev Tuberc 71 (1955) 616-634
45. Katayama H., Yokoyama A., Kohno N., Sakai K., Hiwada K., Yamada H., et al. Production of eosinophilic chemokines by normal pleural mesothelial cells. Am J Respir Cell Mol Biol 26 (2002) 398-403
46. Weber C., Weber K.S., Klier C., Gu S., Wank R., Horuk R., et al. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells. Blood 97 (2001) 1144-1146
47. Locati M., Deuschle U., Massardi M.L., Martinez F.O., Sironi M., Sozzani S., et al. Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Immunol 168 (2002) 3557-3562
48. Makino Y., Cook D.N., Smithies O., Hwang O.Y., Neilson E.G., Turka L.A., et al. Impaired T cell function in RANTES-deficient mice. Clin Immunol 102 (2002) 302-309
49. Algood H.M., and Flynn J.L. CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J Immunol 173 (2004) 3287-3296